Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome.

The Journal of urology - 1 Jul 2010

Yang Jin, Xu Zhigang, Li Jie, Zhang Rong, Zhang Guizheng, Ji Huixiang, Song Bo, Chen Zhiwen

Abstract excerpt

PURPOSE: Varied XPC genetics are related to bladder cancer susceptibility. We determined whether decreased XPC expression influences bladder cancer malignancy and clinical outcome. MATERIALS AND METHODS: Changes in XPC and p53 expression were detected by immunochemistry in 108 bladder cancers, in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to Chi-Square Distribution
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Silencing

Share to Neoplasm Staging

Share to Proportional Hazards Models

Share to Tumor Suppressor Protein p53

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 20488473
DOI: 10.1016/j.juro.2010.03.044

Genes

XPC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20488473-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome.PMID 20488473Read ↗

Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression.Semantic proximity Read ↗

Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.Semantic proximity Read ↗

Association between DNA repair gene polymorphisms and p53 alterations in Japanese patients with muscle-invasive bladder cancer.Semantic proximity Read ↗

Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers.Semantic proximity Read ↗

Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.Semantic proximity Read ↗

Aberrant Promoter Methylation of Multiple Genes during Pathogenesis of Bladder CancerSemantic proximity Read ↗

Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.Semantic proximity Read ↗

E-cadherin gene promoter hypermethylation may contribute to the risk of bladder cancer among Asian populations.Semantic proximity Read ↗

The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulationSemantic proximity Read ↗

p53 Dysfunction by Xeroderma Pigmentosum Group C Defects Enhance Lung Adenocarcinoma Metastasis via Increased Mmp1 ExpressionSemantic proximity Read ↗

17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.